ReP USP - Resultado da busca

Artigo de periodico
Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats (2023)
Cavichioli, Andreza M.; Silva, Thamyris Santos; Grace, Anthony A.; Guimarães, Francisco Silveira ; Gomes, Felipe Villela
Source: Schizophrenia Bulletin. Unidade: FMRP
Subjects: POTENCIAIS DE AÇÃO, NEUROTRANSMISSORES, ESQUIZOFRENIA, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVICHIOLI, Andreza M. et al. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, v. 49, n. 1, p. 68-77, 2023Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbac106. Acesso em: 03 nov. 2024.
APA
Cavichioli, A. M., Silva, T. S., Grace, A. A., Guimarães, F. S., & Gomes, F. V. (2023). Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, 49( 1), 68-77. doi:10.1093/schbul/sbac106
NLM
Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1093/schbul/sbac106
Vancouver
Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1093/schbul/sbac106
Artigo de periodico
What can we learn from animal models to study schizophrenia? (2022)
Crunfli, Fernanda ; Del Bel, Elaine Aparecida ; Gomes, Felipe Villela ; Teles, Caroline Brandão; Zuccoli, Giuliana S.; Chaves Filho, Adriano J. M.; Vieira, Gabriela Maciel ; Amaral, Danyelle Silva; Crippa, José Alexandre de Souza ; Pedrazzi, João Francisco Cordeiro; Macêdo, Danielle S.
Source: Advances in Experimental Medicine and Biology. Unidades: FMRP, FORP
Subjects: ESQUIZOFRENIA, MODELOS ANIMAIS, TRANSTORNOS PSICÓTICOS, NEUROTRANSMISSORES, GLUTAMATOS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUNFLI, Fernanda et al. What can we learn from animal models to study schizophrenia?. Advances in Experimental Medicine and Biology, v. 1400, p. 15-33, 2022Tradução . . Disponível em: https://doi.org/10.1007/978-3-030-97182-3_2. Acesso em: 03 nov. 2024.
APA
Crunfli, F., Del Bel, E. A., Gomes, F. V., Teles, C. B., Zuccoli, G. S., Chaves Filho, A. J. M., et al. (2022). What can we learn from animal models to study schizophrenia? Advances in Experimental Medicine and Biology, 1400, 15-33. doi:10.1007/978-3-030-97182-3_2
NLM
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Vancouver
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Artigo de periodico
Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors (2022)
Souza, Adriana de Jesus; Cortez, Isadora L.; Silva, Nicole R.; Pedrazzi, João Francisco Cordeiro; Domingos, Luana B.; Braga, Matheus Silva; Silva, Thamyris Santos; Del Bel, Elaine Aparecida ; Resstel, Leonardo Barbosa Moraes ; Li, Guanguan; Mian, Md Yeunus; Sharmin, Dishary; Guimarães, Francisco Silveira ; Cook, James M.; Gomes, Felipe Villela
Source: Behavioural Brain Research. Unidades: FORP, FMRP
Subjects: ANSIEDADE, DEPRESSÃO, ANTIPSICÓTICOS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Adriana de Jesus et al. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, v. 428, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2022.113832. Acesso em: 03 nov. 2024.
APA
Souza, A. de J., Cortez, I. L., Silva, N. R., Pedrazzi, J. F. C., Domingos, L. B., Braga, M. S., et al. (2022). Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, 428, 1-11. doi:10.1016/j.bbr.2022.113832
NLM
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Vancouver
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Artigo de periodico
Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention (2022)
Uliana, Daniela L.; Zhu, Xiyu; Gomes, Felipe Villela ; Grace, Anthony A.
Source: Frontiers in Behavioral Neuroscience. Unidade: FMRP
Subjects: DEPRESSÃO, NEUROTRANSMISSORES, PLASTICIDADE NEURONAL, CÓRTEX PRÉ-FRONTAL, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULIANA, Daniela L. et al. Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention. Frontiers in Behavioral Neuroscience, v. 16, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fnbeh.2022.935320. Acesso em: 03 nov. 2024.
APA
Uliana, D. L., Zhu, X., Gomes, F. V., & Grace, A. A. (2022). Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention. Frontiers in Behavioral Neuroscience, 16, 1-15. doi:10.3389/fnbeh.2022.935320
NLM
Uliana DL, Zhu X, Gomes FV, Grace AA. Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention [Internet]. Frontiers in Behavioral Neuroscience. 2022 ; 16 1-15.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fnbeh.2022.935320
Vancouver
Uliana DL, Zhu X, Gomes FV, Grace AA. Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention [Internet]. Frontiers in Behavioral Neuroscience. 2022 ; 16 1-15.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fnbeh.2022.935320
Artigo de periodico
Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis (2022)
Gomes, Felipe Villela
Source: Biological Psychiatry. Unidade: FMRP
Subjects: HIPOCAMPO, TRANSTORNOS PSICÓTICOS, NEUROTRANSMISSORES, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis. Biological Psychiatry, v. 91, n. 2, p. e7-e9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.biopsych.2021.10.019. Acesso em: 03 nov. 2024.
APA
Gomes, F. V. (2022). Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis. Biological Psychiatry, 91( 2), e7-e9. doi:10.1016/j.biopsych.2021.10.019
NLM
Gomes FV. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis [Internet]. Biological Psychiatry. 2022 ; 91( 2): e7-e9.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.biopsych.2021.10.019
Vancouver
Gomes FV. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis [Internet]. Biological Psychiatry. 2022 ; 91( 2): e7-e9.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.biopsych.2021.10.019
Artigo de periodico
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia (2022)
Cortez, Isadora Lopes; Silva, Nicole R.; Rodrigues, Naielly S.; Pedrazzi, João Francisco Cordeiro; Del Bel, Elaine Aparecida ; Mechoulam, Raphael; Gomes, Felipe Villela ; Guimarães, Francisco Silveira
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FORP, FMRP
Subjects: CANABINOIDES, ESQUIZOFRENIA, FARMACOTERAPIA, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTEZ, Isadora Lopes et al. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 117, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2022.110553. Acesso em: 03 nov. 2024.
APA
Cortez, I. L., Silva, N. R., Rodrigues, N. S., Pedrazzi, J. F. C., Del Bel, E. A., Mechoulam, R., et al. (2022). HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 1-9. doi:10.1016/j.pnpbp.2022.110553
NLM
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Vancouver
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Artigo de periodico
GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia (2022)
Kiemes, Amanda; Gomes, Felipe Villela ; Cash, Diana; Uliana, Daniela L.; Simmons, Camilla; Singh, Nisha; Vernon, Anthony C.; Turkheimer, Federico; Davies, Cathy; Stone, James M.; Grace, Anthony A.; Modinos, Gemma
Source: Neuropsychopharmacology. Unidade: FMRP
Subjects: MODELOS ANIMAIS DE DOENÇAS, HIPOCAMPO, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIEMES, Amanda et al. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, v. 47, n. 3, p. 687-695, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41386-021-01213-0. Acesso em: 03 nov. 2024.
APA
Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., et al. (2022). GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, 47( 3), 687-695. doi:10.1038/s41386-021-01213-0
NLM
Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41386-021-01213-0
Vancouver
Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41386-021-01213-0
Artigo de periodico
Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum (2021)
Pedrazzi, João Francisco Cordeiro; Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Joca, Sâmia Regiane Lourenço ; Crippa, José Alexandre de Souza ; Del Bel, Elaine Aparecida
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FMRP, FCFRP, FORP
Subjects: ANFETAMINAS, ANTIPSICÓTICOS, COMPORTAMENTO ANIMAL, CANABINOIDES, METILAÇÃO DE DNA, CÓRTEX PRÉ-FRONTAL, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 111, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2021.110352. Acesso em: 03 nov. 2024.
APA
Pedrazzi, J. F. C., Sales, A. J., Guimarães, F. S., Joca, S. R. L., Crippa, J. A. de S., & Del Bel, E. A. (2021). Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111. doi:10.1016/j.pnpbp.2021.110352
NLM
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Vancouver
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Artigo de periodico
Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention (2021)
Gomes, Felipe Villela ; Grace, Anthony A.
Source: International Journal of Molecular Sciences. Unidade: FMRP
Subjects: AGENTES DOPAMINÉRGICOS, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, HIPOCAMPO, ESTRESSE, GLUTAMATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela e GRACE, Anthony A. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention. International Journal of Molecular Sciences, v. 22, n. 9, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22094467. Acesso em: 03 nov. 2024.
APA
Gomes, F. V., & Grace, A. A. (2021). Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention. International Journal of Molecular Sciences, 22( 9), 1-18. doi:10.3390/ijms22094467
NLM
Gomes FV, Grace AA. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 9): 1-18.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/ijms22094467
Vancouver
Gomes FV, Grace AA. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 9): 1-18.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/ijms22094467
Artigo de periodico
Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors (2020)
Silva, Naielly Rodrigues da; Gomes, Felipe Villela; Sonego, Andreza Buzolin; Silva, Nicole Rodrigues da; Guimarães, Francisco Silveira
Source: Pharmacological Research. Unidade: FMRP
Subjects: CANABINOIDES, ANTIPSICÓTICOS, ESQUIZOFRENIA, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Naielly Rodrigues da et al. Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors. Pharmacological Research, v. 156, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2020.104749. Acesso em: 03 nov. 2024.
APA
Silva, N. R. da, Gomes, F. V., Sonego, A. B., Silva, N. R. da, & Guimarães, F. S. (2020). Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors. Pharmacological Research, 156. doi:10.1016/j.phrs.2020.104749
NLM
Silva NR da, Gomes FV, Sonego AB, Silva NR da, Guimarães FS. Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors [Internet]. Pharmacological Research. 2020 ; 156[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.phrs.2020.104749
Vancouver
Silva NR da, Gomes FV, Sonego AB, Silva NR da, Guimarães FS. Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors [Internet]. Pharmacological Research. 2020 ; 156[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.phrs.2020.104749
Artigo de periodico
Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia (2020)
Sonnenschein, Susan F.; Gomes, Felipe Villela ; Grace, Anthony A.
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: NEUROTRANSMISSORES, HIPOCAMPO, CÓRTEX PRÉ-FRONTAL, TÁLAMO, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONNENSCHEIN, Susan F. e GOMES, Felipe Villela e GRACE, Anthony A. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Frontiers in Psychiatry, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2020.00613. Acesso em: 03 nov. 2024.
APA
Sonnenschein, S. F., Gomes, F. V., & Grace, A. A. (2020). Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Frontiers in Psychiatry, 11. doi:10.3389/fpsyt.2020.00613
NLM
Sonnenschein SF, Gomes FV, Grace AA. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia [Internet]. Frontiers in Psychiatry. 2020 ; 11[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fpsyt.2020.00613
Vancouver
Sonnenschein SF, Gomes FV, Grace AA. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia [Internet]. Frontiers in Psychiatry. 2020 ; 11[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fpsyt.2020.00613
Artigo de periodico
Are CB2 receptors a new target for schizophrenia treatment? (2020)
Cortez, Isadora Lopes; Silva, Naielly Rodrigues da; Guimarães, Francisco Silveira ; Gomes, Felipe Villela
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, ESQUIZOFRENIA, RECEPTORES, NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTEZ, Isadora Lopes et al. Are CB2 receptors a new target for schizophrenia treatment?. Frontiers in Psychiatry, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2020.587154. Acesso em: 03 nov. 2024.
APA
Cortez, I. L., Silva, N. R. da, Guimarães, F. S., & Gomes, F. V. (2020). Are CB2 receptors a new target for schizophrenia treatment? Frontiers in Psychiatry, 11. doi:10.3389/fpsyt.2020.587154
NLM
Cortez IL, Silva NR da, Guimarães FS, Gomes FV. Are CB2 receptors a new target for schizophrenia treatment? [Internet]. Frontiers in Psychiatry. 2020 ; 11[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fpsyt.2020.587154
Vancouver
Cortez IL, Silva NR da, Guimarães FS, Gomes FV. Are CB2 receptors a new target for schizophrenia treatment? [Internet]. Frontiers in Psychiatry. 2020 ; 11[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fpsyt.2020.587154
Artigo de periodico
The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability (2020)
Gomes, Felipe Villela ; Zhu, Xiyu; Grace, Anthony A.
Source: Molecular Psychiatry. Unidade: FMRP
Subjects: MODELOS ANIMAIS, DEPRESSÃO, ESQUIZOFRENIA, NEUROCIÊNCIAS, ESTRESSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela e ZHU, Xiyu e GRACE, Anthony A. The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability. Molecular Psychiatry, v. 25, n. 12, p. 3278-3291, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41380-019-0514-1. Acesso em: 03 nov. 2024.
APA
Gomes, F. V., Zhu, X., & Grace, A. A. (2020). The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability. Molecular Psychiatry, 25( 12), 3278-3291. doi:10.1038/s41380-019-0514-1
NLM
Gomes FV, Zhu X, Grace AA. The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability [Internet]. Molecular Psychiatry. 2020 ; 25( 12): 3278-3291.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41380-019-0514-1
Vancouver
Gomes FV, Zhu X, Grace AA. The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability [Internet]. Molecular Psychiatry. 2020 ; 25( 12): 3278-3291.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41380-019-0514-1
Artigo de periodico
Stress during critical periods of development and risk for schizophrenia (2019)
Gomes, Felipe Villela ; Zhu, Xiyu; Grace, Anthony A.
Source: Schizophrenia Research. Unidade: FMRP
Subjects: ESTRESSE, ESQUIZOFRENIA, TRANSTORNOS PSICÓTICOS, PUBERDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela e ZHU, Xiyu e GRACE, Anthony A. Stress during critical periods of development and risk for schizophrenia. Schizophrenia Research, v. 213, p. 107-113, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2019.01.030. Acesso em: 03 nov. 2024.
APA
Gomes, F. V., Zhu, X., & Grace, A. A. (2019). Stress during critical periods of development and risk for schizophrenia. Schizophrenia Research, 213, 107-113. doi:10.1016/j.schres.2019.01.030
NLM
Gomes FV, Zhu X, Grace AA. Stress during critical periods of development and risk for schizophrenia [Internet]. Schizophrenia Research. 2019 ; 213 107-113.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.schres.2019.01.030
Vancouver
Gomes FV, Zhu X, Grace AA. Stress during critical periods of development and risk for schizophrenia [Internet]. Schizophrenia Research. 2019 ; 213 107-113.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.schres.2019.01.030
Artigo de periodico
Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure (2019)
Klinger, Katharina; Gomes, Felipe Villela ; Rincón-Cortés, Millie; Grace, Anthony A.
Source: European Neuropsychopharmacology. Unidade: FMRP
Subjects: ESTRESSE, ESQUIZOFRENIA, DEPRESSÃO, ADOLESCENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KLINGER, Katharina et al. Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure. European Neuropsychopharmacology, v. 29, n. 10, p. 1127-1137, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.euroneuro.2019.07.134. Acesso em: 03 nov. 2024.
APA
Klinger, K., Gomes, F. V., Rincón-Cortés, M., & Grace, A. A. (2019). Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure. European Neuropsychopharmacology, 29( 10), 1127-1137. doi:10.1016/j.euroneuro.2019.07.134
NLM
Klinger K, Gomes FV, Rincón-Cortés M, Grace AA. Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure [Internet]. European Neuropsychopharmacology. 2019 ; 29( 10): 1127-1137.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.euroneuro.2019.07.134
Vancouver
Klinger K, Gomes FV, Rincón-Cortés M, Grace AA. Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure [Internet]. European Neuropsychopharmacology. 2019 ; 29( 10): 1127-1137.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.euroneuro.2019.07.134
Artigo de periodico
Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity (2018)
Uliana, Daniela L.; Resstel, Leonardo Barbosa Moraes; Grace, Anthony A.
Source: Neuropsychopharmacology. Unidade: FMRP
Subjects: MEDO, ESQUIZOFRENIA, ROEDORES, NEUROFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULIANA, Daniela L. e RESSTEL, Leonardo Barbosa Moraes e GRACE, Anthony A. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity. Neuropsychopharmacology, v. 43, n. 12, p. 2459-2467, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41386-018-0128-3. Acesso em: 03 nov. 2024.
APA
Uliana, D. L., Resstel, L. B. M., & Grace, A. A. (2018). Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity. Neuropsychopharmacology, 43( 12), 2459-2467. doi:10.1038/s41386-018-0128-3
NLM
Uliana DL, Resstel LBM, Grace AA. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity [Internet]. Neuropsychopharmacology. 2018 ; 43( 12): 2459-2467.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41386-018-0128-3
Vancouver
Uliana DL, Resstel LBM, Grace AA. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity [Internet]. Neuropsychopharmacology. 2018 ; 43( 12): 2459-2467.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41386-018-0128-3
Artigo de periodico
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia (2018)
Gomes, Felipe Villela ; Edelson, Jessica R.; Volk, David W.; Grace, Anthony A.
Source: Schizophrenia Research. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, CÉREBRO, CRESCIMENTO E DESENVOLVIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela et al. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, v. 201, p. 254-260, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2018.04.030. Acesso em: 03 nov. 2024.
APA
Gomes, F. V., Edelson, J. R., Volk, D. W., & Grace, A. A. (2018). Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, 201, 254-260. doi:10.1016/j.schres.2018.04.030
NLM
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030
Vancouver
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030
Artigo de periodico
Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders (2017)
Campos, Alline Cristina de; Fogaça, Manoela V.; Scarante, Franciele F.; Joca, Sâmia Regiane Lourenço; Sales, Amanda J.; Gomes, Felipe V.; Sonego, Andreza B.; Rodrigues, Naielly S.; Galve-Roperh, Ismael; Guimarães, Francisco Silveira
Source: Frontiers in Pharmacology. Unidades: FMRP, FCFRP
Subjects: ANSIEDADE, CANABINOIDES, DEPRESSÃO, ESQUIZOFRENIA, SINAPSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Alline Cristina de et al. Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders. Frontiers in Pharmacology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00269. Acesso em: 03 nov. 2024.
APA
Campos, A. C. de, Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., et al. (2017). Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders. Frontiers in Pharmacology, 8. doi:10.3389/fphar.2017.00269
NLM
Campos AC de, Fogaça MV, Scarante FF, Joca SRL, Sales AJ, Gomes FV, Sonego AB, Rodrigues NS, Galve-Roperh I, Guimarães FS. Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2017.00269
Vancouver
Campos AC de, Fogaça MV, Scarante FF, Joca SRL, Sales AJ, Gomes FV, Sonego AB, Rodrigues NS, Galve-Roperh I, Guimarães FS. Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2017.00269
Artigo de periodico
Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders (2016)
Lisboa, Sabrina F.; Gomes, Felipe V.; Guimarães, Francisco Silveira; Campos, Alline Cristina de
Source: Frontiers in Neurology. Unidade: FMRP
Subjects: ANSIEDADE, DEPRESSÃO, CANABINOIDES, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, Sabrina F. et al. Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders. Frontiers in Neurology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fneur.2016.00005. Acesso em: 03 nov. 2024.
APA
Lisboa, S. F., Gomes, F. V., Guimarães, F. S., & Campos, A. C. de. (2016). Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders. Frontiers in Neurology, 7. doi:10.3389/fneur.2016.00005
NLM
Lisboa SF, Gomes FV, Guimarães FS, Campos AC de. Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders [Internet]. Frontiers in Neurology. 2016 ; 7[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fneur.2016.00005
Vancouver
Lisboa SF, Gomes FV, Guimarães FS, Campos AC de. Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders [Internet]. Frontiers in Neurology. 2016 ; 7[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fneur.2016.00005
Trabalho de evento-resumo
Repeated cannabidiol treatment reverses behavioral changes in a model of schizophrenia based on antagonism of NMDA receptors (2016)
Rodrigues, Naielly; Silva, Nicole R.; Gomes, Felipe V.; Guimarães, Francisco Silveira
Source: Abstracts. Conference titles: Annual International Cannabinoid Research Society Symposium on the Cannabinoids. Unidade: FMRP
Subjects: ESQUIZOFRENIA, CANABINOIDES, CANNABIS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Naielly et al. Repeated cannabidiol treatment reverses behavioral changes in a model of schizophrenia based on antagonism of NMDA receptors. 2016, Anais.. Bukowina: ICRS, 2016. . Acesso em: 03 nov. 2024.
APA
Rodrigues, N., Silva, N. R., Gomes, F. V., & Guimarães, F. S. (2016). Repeated cannabidiol treatment reverses behavioral changes in a model of schizophrenia based on antagonism of NMDA receptors. In Abstracts. Bukowina: ICRS.
NLM
Rodrigues N, Silva NR, Gomes FV, Guimarães FS. Repeated cannabidiol treatment reverses behavioral changes in a model of schizophrenia based on antagonism of NMDA receptors. Abstracts. 2016 ;[citado 2024 nov. 03 ]
Vancouver
Rodrigues N, Silva NR, Gomes FV, Guimarães FS. Repeated cannabidiol treatment reverses behavioral changes in a model of schizophrenia based on antagonism of NMDA receptors. Abstracts. 2016 ;[citado 2024 nov. 03 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration